Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Strategies for Successful Process Scale-Up
Advanced Tools Provide Better Solutions for Critical Aspect of Biologics Development
- Scaling up biologics production from the bench to clinical and commercial scale is a central consideration of process design and development. Issues, challenges, and new technologies in scale-up were all discussed at “BioProcess International Europe” held in Vienna recently. The meeting began with a case study of scale-up in ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.